Less
More
-
Posts: 62474
-
Thank you received: 36
-
-
22 Jun 2013 15:39 #142575
by chairman
(Reuters) - The U.S. Food and Drug Administration approved Theravance Inc's antibiotic lung drug to treat a type of bacterial pneumonia affecting hospitalized patients, particularly those on ventilators.
The drug, Vibativ, will reach the market in the third quarter of 2013 for its expanded use. The drug is already approved in the United States and Canada to treat bacterial skin infections.
The disease, also known as nosocomial pneumonia, is a serious lung infection as patients, particularly those on ventilators, often cannot fight the infection.
The regulator said on Friday that Vibativ will be prescribed only when alternative treatments are not suitable and the expanded use is to treat only bacterial pneumonia due to staphylococcus aureus.
Always tell someone how you feel because opportunities are lost in the blink of an eye but regret can last a lifetime.
cricketwindies.com/forum/
Please Log in or Create an account to join the conversation.
Less
More
-
Posts: 93768
-
Thank you received: 44
-
-
22 Jun 2013 16:03 #142577
by ketchim
Viagra Patent expired in England last night.
Dem gonna get a cheap generic version !
Englishmen will be walking stiffs ....hahaha
Please Log in or Create an account to join the conversation.
-
Forum
-
Political Opinions, Commentaries on Current Issues
-
The Water Cooler!
-
FDA approves Theravance's lung drug for wider use
Time to create page: 0.182 seconds